ZIM Laboratories has received a Certificate of Good Manufacturing Practice (GMP) Compliance from Australia's Therapeutic Goods Administration (TGA) for its manufacturing facility at B-21/22, MIDC Area, Kalmeshwar, Nagpur, Maharashtra.

Issued on 15 October 2026, the certification follows an on-site inspection conducted on 18 April and 20–21 April 2026. It confirms that the facility complies with the requirements of the PIC/S Guide to Good Manufacturing Practice for Medicinal Products dated 25 August 2023.

The certification covers the manufacture of non-sterile finished products across both registered and listed therapeutic goods categories. Its scope includes hard capsules, solid unit dosage forms, tablets, granules, powders for suspension, wafers and soluble films.

The certification supports the Company's efforts to develop manufacturing partnerships and pursue opportunities in the Australian market, subject to applicable product-specific regulatory approvals.